Login / Signup

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial.

Ettore BeghiElisabetta PupilloElisa BianchiValentina BonettoSilvia LuottiLaura PasettoCaterina BendottiMassimo TortaroloFrancesca SironiLaura CamporealeAlexander V ShermanSabrina PaganoniAda ScognamiglioFabiola De MarchiPaolo BongioanniRenata Del CarratoreClaudia CaponnettoLuca DiamantiDaniele MartinelliAndrea CalvoMassimiliano MirabellaAlessandro PadovaniStefano Cotti PiccinelliClaudia RicciStefania Dalla GiacomaNicoletta De AngelisMaurizio InghilleriRossella SpataroVincenzo La BellaGiancarlo LogroscinoChristian LunettaClaudia TarlariniJessica MandrioliIlaria MartinelliCecilia SimoniniElisabetta ZucchiMaria Rosaria MonsurròDario RicciardiFrancesca TrojsiNilo RivaMassimo FilippiIsabella Laura SimoneGianni SorarùCristina SperaLucia FlorioSonia MessinaMassimo RussoGabriele SicilianoAmelia ConteMaria Valeria SaddiNicola CarboniLetizia Mazzininull null
Published in: European journal of neurology (2022)
The positive effects of RNS60 on selected measures of respiratory and bulbar function warrant further investigation.
Keyphrases
  • double blind
  • phase ii
  • placebo controlled
  • clinical trial
  • phase iii
  • study protocol
  • open label
  • randomized controlled trial
  • respiratory tract